# Hong Kong stocks gain as technology and pharmaceutical shares lead the market

- Link: https://www.directorstalkinterviews.com/hong-kong-stocks-gain-as-technology-and-pharmaceutical-shares-lead-the-market/4121265490
- Published: 2026-10-06T09:38:00+01:00
- Author: Amilia Stone

Hong Kong shares moved higher on Tuesday, with pharmaceutical and technology stocks
leading gains as stronger global market sentiment offset continued weakness among
property developers.

The Hang Seng Index was up 0.8% at 24,240 by the latest reported level, while the
Hang Seng China Enterprises Index gained 0.82%. The Hang Seng Tech Index rose 0.87%,
while the Hang Seng Biotech Index advanced by almost 3%. The gains followed a stronger
session on Wall Street, where technology stocks benefited from continued optimism
surrounding artificial intelligence and corporate deal activity.

The technology-led move provides a further indication that investor attention remains
concentrated on companies with exposure to artificial intelligence, technology and
biotechnology. WuXi Biologics and Sino Biopharmaceutical were among the strongest
performers within the Hang Seng Index, rising 4.2% and 4.1% respectively. Sunny 
Optical, Baidu, Kuaishou and Alibaba also recorded gains of between 2.8% and 3.7%.

Other technology-related names also moved higher. Z.AI Co. gained 7.8%, while Tencent
rose 1%. Genscript Biotech advanced 5.5%, MiniMax increased 4.3% and Wuxi Biologics
gained 3.3%.

The broader market was also supported by lower oil prices. Brent crude was trading
around US$100 a barrel after falling 1.9% in the previous session, with increased
Middle East exports and a commitment from G7 nations to boost supplies helping to
ease some pressure on energy markets.

The move in Hong Kong followed a positive session in US markets, where the Nasdaq
reached a record close. The technology rally has provided support for Asian markets,
although higher US Treasury yields remain a consideration for equity valuations.
Treasury yields were hovering around 5.31%, keeping interest rate and funding conditions
firmly in focus.

_**Fidelity China Special** **Situations PLC** (LON:FCSS), the UK’s largest China
Investment Trust, capitalises on Fidelity’s extensive, locally-based analyst team
to find attractive opportunities in a market too big to ignore._

Share on:
